| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/13/2011 | WO2011004325A1 Pharmaceutical compositions and therapeutic methods employing a combination of a manganese complex compound and a non-manganese complex form of the compound |
| 01/13/2011 | US20110009631 Phenethanolamine Derivatives for Treatment of Respiratory Diseases |
| 01/13/2011 | US20110009625 Novel compounds |
| 01/13/2011 | US20110009471 Oligonucleotide analogues and methods utilizing the same |
| 01/13/2011 | US20110009466 Methods of increasing gene expression through rna protection |
| 01/13/2011 | US20110009465 3-phenoxymethylpyrrolidine compounds |
| 01/13/2011 | US20110009449 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 01/13/2011 | US20110009447 Substituted Benzoic Acid Amides and Use thereof for the Inhibition of Angiogenesis |
| 01/13/2011 | US20110009423 Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 01/13/2011 | US20110009389 Imidazole derivative, their production and use |
| 01/13/2011 | US20110009370 Method to enhance tissue regeneration |
| 01/13/2011 | US20110009367 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 01/13/2011 | US20110009361 Design and selection of medicaments that modulate the function and activity of interleukin 13 |
| 01/13/2011 | US20110009352 Restorative agent for antibacterial peptide production ability |
| 01/13/2011 | US20110009347 Combination therapy for the treatment of diabetes |
| 01/13/2011 | US20110009344 Control of radiation injury |
| 01/13/2011 | US20110009343 Modulators of amyloid aggregation |
| 01/13/2011 | US20110009333 Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
| 01/13/2011 | US20110009323 Non-immunoglobulin antigen binding scaffolds for inhibiting angiogenesis and tumor growth |
| 01/13/2011 | US20110009318 Transdermal Compositions and Methods for Treatment of Fibromyalgia and Chronic Fatigue Syndrome |
| 01/13/2011 | US20110008762 Methods for Preserving Organs and Tissues |
| 01/13/2011 | US20110008470 Carrageenan modified by ion-exchange process |
| 01/13/2011 | US20110008467 Sodium thiosulfate-containing pharmaceutical compositions |
| 01/13/2011 | US20110008446 Method of Drug Delivery |
| 01/13/2011 | US20110008444 Composition for the formation of gels |
| 01/13/2011 | US20110008443 Photocrosslinked biodegradable hydrogel |
| 01/13/2011 | US20110008438 Bone Repair Composition and a Method of Making the Same |
| 01/13/2011 | US20110008435 Nanoparticulate and Controlled Release Compositions Comprising Aryl-Heterocyclic Compounds |
| 01/13/2011 | US20110008425 Treatment for Attention-Deficit Hyperactivity Disorder |
| 01/13/2011 | US20110008415 Novel lipophilic compositions and uses thereof |
| 01/13/2011 | US20110008397 Compartmental extract compositions for tissue engineering |
| 01/13/2011 | US20110008373 Prodrugs of cc-1065 analogs |
| 01/13/2011 | US20110008354 Antibodies to apo-2 receptor polypeptides |
| 01/13/2011 | US20110008347 Cancer-related protein kinases |
| 01/13/2011 | US20110008344 Fusion partner cell line for preparation of hybrid cells expressing human antibodies |
| 01/13/2011 | US20110008330 Compositions and methods of tolerizing a primate to an antigen |
| 01/13/2011 | US20110008324 Antibody Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Uses Thereof |
| 01/13/2011 | US20110008321 Vectors, Host Cells, and Methods of Production and Uses |
| 01/13/2011 | US20110008272 Use of Creatine or Creatine Compounds for Skin Preservation |
| 01/13/2011 | US20110008253 Process for production of heterodimers of glutamic acid |
| 01/13/2011 | US20110008252 Stabalised 99mtc compositions |
| 01/13/2011 | CA2767556A1 Azabicyclo compound and salt thereof |
| 01/13/2011 | CA2767339A1 Pharmaceutical compositions and therapeutic methods employing a combination of a manganese complex compound and a non-manganese complex form of the compound |
| 01/13/2011 | CA2765529A1 Acid pump antagonist for treatment of diseases involved in abnormal gastrointestinal motility |
| 01/13/2011 | CA2765463A1 Methods for treating or preventing fatigue |
| 01/13/2011 | CA2764126A1 Diphenyl sulfide derivatives and medicines containing same as active ingredient |
| 01/12/2011 | EP2272959A1 BMP-11 compositions |
| 01/12/2011 | EP2272870A1 Process for manufacturing immunoglobulins for intravenous administration and other immunoglobulin-like products |
| 01/12/2011 | EP2272869A2 Angiopoietin-2 specific binding agents |
| 01/12/2011 | EP2272854A1 Novel glycolipid and use thereof |
| 01/12/2011 | EP2272844A1 Five-membered ring compound |
| 01/12/2011 | EP2272835A1 Novel five-membered ring compound |
| 01/12/2011 | EP2272833A1 2-(3-(4-(2-t-Butyl-6-trifluoromethylpyridin-4-yl)piperazin-1-yl)propylmercapto)pyrimidin-4-ol-fumarate |
| 01/12/2011 | EP2272825A2 N-Protected amino hydroxy adamantane carboxylic acid and process for its preparation |
| 01/12/2011 | EP2272520A1 Pharmaceutical composition and poria extract useful for enhancing absorption of nutrients |
| 01/12/2011 | EP2272516A2 4-Oxoquinoline compound and use thereof as HIV integrase inhibitor |
| 01/12/2011 | EP2272513A1 Pharmaceutical compositions for treating cancer |
| 01/12/2011 | EP2272512A1 Pharmaceutical compositions for treating cancer |
| 01/12/2011 | EP2271621A1 Pyridyl derivatives as cftr modulators |
| 01/12/2011 | EP2271326A1 Modulation of fibroblast activity |
| 01/12/2011 | EP1517907B1 Azabicyclo-octane and nonane derivatives with ddp-iv inhibiting activity |
| 01/12/2011 | EP1490357B1 Toluene solvate of darifenacin |
| 01/12/2011 | EP1402266B1 Reducing RISK OF COMPLICATIONS OF PREMATURITY |
| 01/12/2011 | EP1401458B1 Composition consisting of phy906 and chemotherapeutic agents |
| 01/12/2011 | EP1375434B1 Method and device for manufacturing advanced water containing ultra-fine gold particles |
| 01/12/2011 | CN1943781B Orally administered peptides to ameliorate atherosclerosis |
| 01/12/2011 | CN1894273B Peptide inhibiting angiotensin converting enzyme |
| 01/12/2011 | CN101946003A Anti-adam-15 antibodies and utilization of the same |
| 01/12/2011 | CN101945663A Bioassay method for yokukansan |
| 01/12/2011 | CN101945659A Adrenomedullin production enhancer |
| 01/12/2011 | CN101942003A Compound and preparation method thereof |
| 01/12/2011 | CN101941977A Antitumoral analogs of lamellarins |
| 01/12/2011 | CN101941959A Application of dihydroxy-benzopyrone compounds in preparing medicaments for preventing and treating bone fracture and osteoporosis |
| 01/12/2011 | CN101940763A Chinese medicinal herb for treating jaundice (yang jaundice) |
| 01/12/2011 | CN101940576A Compound and medicinal use thereof |
| 01/12/2011 | CN101940571A Anti-angiogenic agents and methods of use |
| 01/12/2011 | CN101940570A Composite of ligustrazine phosphate and danshensu and application thereof |
| 01/12/2011 | CN101507795B Traditional Chinese medicine composite capable of preventing and treating chronic fatigue and preparation method thereof |
| 01/12/2011 | CN101461874B Ultrasonic auxiliary method for simultaneously extracting areca alkaloids and coloring matter from betel nut |
| 01/12/2011 | CN101333215B Method for synthesizing sunitinib alkali |
| 01/12/2011 | CN101094851B Novel compound having lipase inhibitory activity |
| 01/11/2011 | US7868225 Artichoke hybrid named ‘PS-H2015’ |
| 01/11/2011 | US7868028 blocking voltage-sensitive sodium channels of neurons in a mammal comprising administering 1-benzyl-2-imino-3-(2-hydroxy-3-phenoxypropyl)benzimidazole; analgesics; neuroprotectants; anticonvulsants |
| 01/11/2011 | US7868002 Deazapurines and uses thereof |
| 01/11/2011 | US7867986 Enhanced drug delivery in transdermal systems |
| 01/11/2011 | US7867982 administering to a primate(human) an immunogenic composition containing modified virus Ankara (MVA), a replication-deficient strain of vaccinia virus, expressing human immunodeficiency virus (HIV) env, gag, and pol genes to induce a CD8+T cell immune |
| 01/11/2011 | US7867973 comprises follistatin domain I; free of an amino acid sequence represented by formula (I): Cys-(X1)a-Cys-(X2)b-Cys-(X3)c-Cys-(X4)d-Cys-(X5)e-Cys-(X6)f-Cys-(X7)g-Cys-(X8)h-Cys-(X9)i-Cys [x=natural amino acids]; inhibiting GDF-8 activity without inhibiting activin activity |
| 01/11/2011 | US7867516 Tablet with masked odor or bitterness; especially with a photostabilizer |
| 01/11/2011 | CA2472149C New fluorenecarboxylic acid esters, process for the manufacture thereof and use thereof as medicaments |
| 01/11/2011 | CA2469876C Benzothiazoles |
| 01/11/2011 | CA2468824C Hexacyclic compounds |
| 01/11/2011 | CA2453974C 4-(benzylideneamino)-3-(methylsulfanyl)-4h-1,2,4-triazin-5-one derivatives having a pde iv-inhibiting and tnf-antagonistic action for the treatment of heart diseases and allergies |
| 01/11/2011 | CA2451678C Azaindoles |
| 01/11/2011 | CA2436891C Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors |
| 01/11/2011 | CA2422054C Bicyclic heteroaromatic compounds |
| 01/11/2011 | CA2420592C Fused pyrrolocarbazoles against inflammation |
| 01/11/2011 | CA2411778C Organic compounds |
| 01/11/2011 | CA2407593C Fused heteroaryl derivatives |
| 01/11/2011 | CA2400486C Aniline-derived ligands for the thyroid receptor |
| 01/11/2011 | CA2387095C Compound with growth hormone releasing properties |